Literature DB >> 29752524

The clinical features of cardiac involvement in patients with severe thrombotic thrombocytopenic purpura.

Aude-Marie Fourmont1,2, Lara Zafrani1,2, Eric Mariotte1,2, Lionel Galicier1,2, Bérangère Joly1,2, Sybille Merceron1,2, Rémi Bertinchamp1,2, Virginie Lemiale1,2, Audrey de Jong1,2, Sandrine Valade1,2, Michael Darmon1,2, Agnès Veyradier1,2, Elie Azoulay3,4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29752524     DOI： 10.1007/s00134-018-5216-7

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN： 0342-4642            Impact factor:   17.440


× No keyword cloud information.
  5 in total

1.  Understanding organ dysfunction in thrombotic thrombocytopenic purpura.

Authors:  Pier Mannuccio Mannucci
Journal:  Intensive Care Med       Date:  2015-01-20       Impact factor: 17.440

2.  Cardiac troponin-I on diagnosis predicts early death and refractoriness in acquired thrombotic thrombocytopenic purpura. Experience of the French Thrombotic Microangiopathies Reference Center.

Authors:  Y Benhamou; P-Y Boelle; B Baudin; S Ederhy; J Gras; L Galicier; E Azoulay; F Provôt; E Maury; F Pène; J-P Mira; A Wynckel; C Presne; P Poullin; J-M Halimi; Y Delmas; T Kanouni; A Seguin; C Mousson; A Servais; D Bordessoule; P Perez; M Hamidou; A Cohen; A Veyradier; P Coppo
Journal:  J Thromb Haemost       Date:  2014-12-18       Impact factor: 5.824

3.  Unresponsive thrombotic thrombocytopenic purpura in critically ill adults.

Authors:  Eric Mariotte; Alice Blet; Lionel Galicier; Michael Darmon; Nathalie Parquet; Etienne Lengline; David Boutboul; Emmanuel Canet; Richard Traineau; Benoît Schlemmer; Agnès Veyradier; Elie Azoulay
Journal:  Intensive Care Med       Date:  2013-04-03       Impact factor: 17.440

4.  Epidemiology and pathophysiology of adulthood-onset thrombotic microangiopathy with severe ADAMTS13 deficiency (thrombotic thrombocytopenic purpura): a cross-sectional analysis of the French national registry for thrombotic microangiopathy.

Authors:  Eric Mariotte; Elie Azoulay; Lionel Galicier; Eric Rondeau; Fouzia Zouiti; Pierre Boisseau; Pascale Poullin; Emmanuel de Maistre; François Provôt; Yahsou Delmas; Pierre Perez; Ygal Benhamou; Alain Stepanian; Paul Coppo; Agnès Veyradier
Journal:  Lancet Haematol       Date:  2016-04-16       Impact factor: 18.959

Review 5.  Myocardial necrosis in patients with thrombotic thrombocytopenic purpura: pathophysiology and rationale for specific therapy.

Authors:  David C Sane; Nathan P Streer; John Owen
Journal:  Eur J Haematol       Date:  2008-11-10       Impact factor: 2.997
  5 in total
  2 in total

1.  Expert statement on the ICU management of patients with thrombotic thrombocytopenic purpura.

Authors:  Elie Azoulay; Philippe R Bauer; Eric Mariotte; Lene Russell; Paul Knoebl; Ignacio Martin-Loeches; Frédéric Pène; Kathryn Puxty; Pedro Povoa; Andreas Barratt-Due; Jose Garnacho-Montero; Julia Wendon; Laveena Munshi; Dominique Benoit; Michael von Bergwelt-Baildon; Marco Maggiorini; Paul Coppo; Spero Cataland; Agnès Veyradier; Andry Van de Louw
Journal:  Intensive Care Med       Date:  2019-10-07       Impact factor: 17.440

Review 2.  Severe Thrombotic Thrombocytopenic Purpura (TTP) with Organ Failure in Critically Ill Patients.

Authors:  Sofiane Fodil; Lara Zafrani
Journal:  J Clin Med       Date:  2022-02-19       Impact factor: 4.241
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.